Alzheimer’s: What Treatment Options Are Being Explored
Alzheimer’s: What treatment options are being explored?
Although there is yet no cure for Alzheimer’s, the field is at a critical crossroads, which is prompting further study. A single, magical “cure” for this complicated disease is unlikely to emerge. The recent historic approval of a drug to delay the progression of Alzheimer’s, together with a deeper understanding of the disease, is strengthening … Continue reading "Alzheimer’s: What treatment options are being explored?"
A Sugar Molecule In The Blood May Predict Early Alzheimer’s
A sugar molecule in the blood may predict early Alzheimer’s
Early diagnosis and treatment of Alzheimer’s require reliable and cost-effective screening procedures. Recently, scientists at the Karolinska Institutet in Sweden found a link between a specific kind of blood sugar molecule and tau levels, a protein involved in the development of severe dementia. The research published in Alzheimer’s & Dementia may lead to a quick … Continue reading "A sugar molecule in the blood may predict early Alzheimer’s"
Researchers Discover A Genetic Variant That Protects Against Alzheimer’s
Researchers discover a genetic variant that protects against Alzheimer’s
Sometimes, a single outlier of a patient case might lead to the emergence of new research and the elucidation of disease-related facts. Researchers frequently draw links between the issues and solutions when they find such a case, which can result in even more compelling and convincing theories regarding the root of the problem and the … Continue reading "Researchers discover a genetic variant that protects against Alzheimer’s"
Can Anxiety Lead To Alzheimer’s
Can Anxiety Lead to Alzheimer’s?
Everybody experiences anxiety from time to time. It results from the fear or the worry that something unpleasant will happen. Anxiety disorders, such as Generalized Anxiety Disorder (GAD), PTSD, panic disorder, agoraphobia, and social anxiety disorder, are characterized by excessive fear and anxiety that interfere with a person’s daily life. When feeling anxious, a person … Continue reading "Can Anxiety Lead to Alzheimer’s?"
Diet Help Prevent Or Treat Alzheimer’s
Can diet help prevent or treat Alzheimer’s?
There are claims that several diets and supplements can help with Alzheimer’s. However, people should be aware that there is no proof that any specific diet or nutrient helps prevent or treat the disease, despite some research suggesting a link between cognitive performance and particular foods or nutrients. Although no specific diet helps prevent or … Continue reading "Can diet help prevent or treat Alzheimer’s?"
Sound And Light As Potential Alzheimer’s Treatment
Sound and Light as Potential Alzheimer’s Treatment
A new study describes the first human trials of an experimental cure for Alzheimer’s that uses sound and light. The preliminary findings are intriguing, with the novel treatment resulting in some neurological and cognitive improvements. However, the small trial size implies further research is needed before anyone can claim that this therapy works. According to … Continue reading "Sound and Light as Potential Alzheimer’s Treatment"
Exercise Affect The Progression Of Alzheimer’s
Can Exercise Affect the Progression of Alzheimer’s?
Scientists have understood for a long time that exercise is beneficial to the body. They are demonstrating in recent years how good it is for the brain, too. Regular physical activity seems to be one of the most effective things you can do to lower your chance of developing dementia out of all the lifestyle … Continue reading "Can Exercise Affect the Progression of Alzheimer’s?"
Frontotemporal Dementia Differs From Alzheimer’s
How Frontotemporal Dementia Differs From Alzheimer’s
Although both frontotemporal dementia (FTD) and Alzheimer’s can result in dementia, the affected brain regions and, as a result, the symptoms differ significantly between the two. Knowing the differences between frontotemporal dementia and Alzheimer’s might assist in lowering the incidence of misdiagnosis, which may promote early treatment, better health outcomes, and improved life quality. Understanding … Continue reading "How Frontotemporal Dementia Differs From Alzheimer’s"
Fructose May Contribute To Alzheimer’s
Fructose May Contribute to Alzheimer’s: Study
According to a recent study from the University of Colorado Anschutz Medical Campus, increased fructose intake may be a chief cause of Alzheimer’s. An ancient human foraging drive, fueled by fructose synthesis in the brain, may provide insights into Alzheimer’s development and potential treatment. The study1, published in The American Journal of Clinical Nutrition, provides … Continue reading "Fructose May Contribute to Alzheimer’s: Study"
World’s Youngest Alzheimer’s Case
Neurologists Report World’s Youngest Alzheimer’s Case
Neurologists at a memory clinic in China have diagnosed a 19-year-old man with Alzheimer’s, making him the youngest person in the world with the condition. According to a recent case study published in the Journal of Alzheimer’s Disease, a 19-year-old male from China who has had memory problems since age 17 was diagnosed with dementia. … Continue reading "Neurologists Report World’s Youngest Alzheimer’s Case"
Brain Stimulation May Help Improve Alzheimer’s Symptoms
Brain Stimulation May Help Improve Alzheimer’s Symptoms: Study
Researchers at Charité – Universitätsmedizin Berlin have discovered a brain network that, when stimulated, can improve Alzheimer’s symptoms. Deep brain stimulation (DBS) is a surgical procedure used to treat specific neurological diseases such as Parkinson’s disease, essential tremor, epilepsy, and dystonia. More than 160,000 individuals receive this therapy annually. Several psychiatric conditions, such as drug … Continue reading "Brain Stimulation May Help Improve Alzheimer’s Symptoms: Study"
Two Significant Alzheimer’s Risk
Two Significant Alzheimer’s Risk Factors Affect Men More Than Women
Researchers from the University of Alberta have found that two crucial risk factors for Alzheimer’s disease have substantially different effects on men and women. Women are diagnosed with Alzheimer’s disease at a higher rate than men. One explanation for this is that women live longer than men, but other neurological and hormonal changes in midlife … Continue reading "Two Significant Alzheimer’s Risk Factors Affect Men More Than Women"
New Blood Test Can Accurately Predict Alzheimer’s
New Blood Test Can Accurately Predict Alzheimer’s Years Before First Symptoms Appear
A new blood test can identify a hidden toxin that causes Alzheimer’s years before symptoms such as memory loss or confusion appear. It could considerably speed up the diagnosis if further tested and scaled up. To detect the onset of Alzheimer’s years before any signs of cognitive impairment manifest, researchers have created a novel laboratory … Continue reading "New Blood Test Can Accurately Predict Alzheimer’s Years Before First Symptoms Appear"
FDA Has Granted Accelerated Approval For Leqembi
FDA has Granted Accelerated Approval for Leqembi
Leqembi (lecanemab-irmb), a medication for treating Alzheimer’s, received approval from the U.S. Food and Drug Administration via the Accelerated Approval pathway on January 6th, 2023. Leqembi is the second drug in a newly approved class for Alzheimer’s that addresses the illness’s basic pathophysiology. These drugs are a significant step forward in the ongoing endeavor to … Continue reading "FDA has Granted Accelerated Approval for Leqembi"
ChatGPT Aid In The Early Detection Of Alzheimer’s
Can the AI Driving ChatGPT Aid in the Early Detection of Alzheimer’s?
According to researchers, the artificial intelligence that powers the chatbot program ChatGPT—famous for its capacity to produce human-like responses when instructed—could aid in the early detection of Alzheimer’s. Recent research from Drexel University’s School of Biomedical Engineering, Science, and Health Systems has revealed that the GPT-3 program from OpenAI can recognize cues from spontaneous speech … Continue reading "Can the AI Driving ChatGPT Aid in the Early Detection of Alzheimer’s?"
Insulin Resistance In An Alzheimer’s Patient’s Brain
What Causes Insulin Resistance in An Alzheimer’s Patient’s Brain?
The prevalence of neurodegenerative conditions like Alzheimer’s disease rises as the population ages. Proteinopathies, abnormal protein buildups in the brain that impede neuronal function, distinguish these disorders. For instance, the accumulation of beta-amyloid and tau proteins is responsible for Alzheimer’s. Trying to lessen amyloid-beta peptide and tau protein aggregation in neurons is the most extensively … Continue reading "What Causes Insulin Resistance in An Alzheimer’s Patient’s Brain?"
Children Exposed To Lead May Experience Dementia Symptoms Earlier
Children Exposed to Lead may Experience Dementia Symptoms Earlier
Lead is known to harm children’s developing brains, and a recent study indicates that the consequences might last into old age. According to the study, lead exposure throughout childhood may result in lower cognitive abilities later in life, implying that people may develop dementia symptoms sooner. Although scientists have long known that lead exposure causes … Continue reading "Children Exposed to Lead may Experience Dementia Symptoms Earlier"
Viruses Play A Role In Alzheimer’s
More Evidence Suggests That Viruses Play a Role in Alzheimer’s
Viruses have been considered a controversial risk factor for Alzheimer’s for decades. It is a contentious hypothesis regarding the disease, frequently brushed aside by specialists as a dubious offshoot of accepted knowledge. However, research continued to establish whether they have a role in the development of Alzheimer’s. Two recent studies have lent some support to … Continue reading "More Evidence Suggests That Viruses Play a Role in Alzheimer’s"
Potential Alzheimer’s Drug Fails Roche Trial
A Setback: Potential Alzheimer’s Drug Fails Roche Trial
The failure of a test medicine to reduce the Alzheimer’s course in international clinical trials has dealt another blow to hopes for a cure for the disease. The possible drug gantenerumab by Roche failed to slow clinical decline in patients with early Alzheimer’s in two phase-III trials. On November 14th, 2022, the Swiss pharmaceutical company … Continue reading "A Setback: Potential Alzheimer’s Drug Fails Roche Trial"
Surprising New Theory Explains What Might Cause Alzheimer’s
Surprising New Theory Explains What Might Cause Alzheimer’s
One of the most investigated questions in Alzheimer’s research is its cause. The accepted theory for more than a century was that amyloid plaque formation in the brain resulted in the disease. However, a recent study has challenged this prevailing hypothesis, claiming that the disease results due to a decline in levels of a specific … Continue reading "Surprising New Theory Explains What Might Cause Alzheimer’s"